Azenta (AZTA) Capital Expenditures Growth (1y) (2011 - 2026)
Azenta (AZTA) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -27.50% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -12.80% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 19.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 67.16% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 0.91% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -42.55% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -24.55% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 10.63% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -17.14% |
| 10 | Azenta | 1.69 Bn | 1.37 Bn | 198.10 Mn | 86.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86.68% |
| Mar 31, 2026 | 83.52% |
| Dec 31, 2025 | -26.41% |
| Jun 30, 2025 | -57.90% |
| Mar 31, 2025 | 182.12% |
| Dec 31, 2024 | -31.36% |
| Sep 30, 2024 | -169.10% |
| Jun 30, 2024 | 18,228.87% |
| Mar 31, 2024 | 7.97% |
| Dec 31, 2023 | -12.08% |
| Sep 30, 2023 | 173.77% |
| Jun 30, 2023 | -100.92% |
| Mar 31, 2023 | -137.82% |
| Dec 31, 2022 | -30.24% |
| Sep 30, 2022 | -372.16% |
| Jun 30, 2022 | 69.74% |
| Mar 31, 2022 | 151.52% |
| Dec 31, 2021 | 20.90% |
| Sep 30, 2021 | 77.74% |
| Jun 30, 2021 | 6.58% |